Standard Document
First Edition
Method Evaluation

CLSI LDTStage1

LDT Regulatory Guidance

The US Food and Drug Administration (FDA) 21 CFR Parts 820.198, 803, and 806 requirements apply to enforcement discretion for laboratory-developed tests (LDTs), scheduled to take effect on 6 May, 2025. This document provides guidance for laboratories preparing to adhere to the FDA requirements when establishing and implementing LDTs.

March 10, 2025
Lucia M. Berte, MA, MLS(ASCP)SBB, DLM, CQA(ASQ)CMQ/OE

{{FormatPrice(currentPrice)}}

Free

{{FormatPrice(nonMemberPrice)}} List Price
This is your member pricing.
Notify Me About New Editions
Product Details
LDTStage1E
978-1-68440-276-2
20
Authors
Lucia M. Berte, MA, MLS(ASCP)SBB, DLM, CQA(ASQ)CMQ/OE
Authors
Lucia M. Berte, MA, MLS(ASCP)SBB, DLM, CQA(ASQ)CMQ/OE